跳至主要内容
临床试验/IRCT201212012269N2
IRCT201212012269N2已完成2 期

A survey of effect of iron supplementation(ferrous sulfate) versus placebo on attention-deficit/hyperactivity disorder symptoms in children under Methylphenidate treatment

Vice chancellor for research, Guilan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
4 years 至 15 years(—)
性别
All

入选标准

  • 1. Children with attention-deficit/hyperactivity disorder based on DSM-IV TR and under Methylphenidate treatment
  • 2. Lack of anemia (Hemoglobin lower than 11 g/dl)
  • 3. Blood ferritin level lower than 30 ng/ml
  • Exclusion criteria:
  • 1. Comorbidity of attention-deficit/hyperactivity disorder with other psychiatric disorders
  • 2. Serious and chronic medical disorders (such as malnutrition)
  • 3. Mental retardation
  • 4. Recent inflammation or infection
  • 5. Use of psychopharmacological medications
  • 6. Iron supplementation consumption during recent 3 months, or contraindication for use it.
  • 7.Severe fever (because of pseudo increase in ferritin level)
  • 8.Hypothyroidism (because of pseudo decrease in ferritin level)

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Guilan University of Medical Sciences

相似试验